top of page
HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
In the design of paediatric PK and safety studies, use weight-based dosing and enroll all children above 4 weeks concurrently, unless a strong rationale exists for not doing so.
Pharmaceutical companies
Sub-Actions & Milestones
Use weight-based dosing and enroll all children above 4 weeks concurrently in the design of paediatric PK and safety studies
Pharmceutical Companies
-
-
-
-
-
-
-
-
-
-
Updates
Notes
Responsible
bottom of page